MTHFD2 and bladder transitional cell carcinoma: Furthermore, the MTHFD2 expression was found to be related to the expression level and copy number variance of several hyperprogression predictive genes, suggesting its potential to predict the hyperprogression in BLCA patients treated with ICB (63).